Articles tagged ‘acute coronary syndrome’

Clinicians can access hundreds of cardiovascular (CV) clinical trials searchable by trial acronyms, authors and medication, through a new app. ‘Quest’ has been launched by AstraZeneca for healthcare professionals responsible for managing CV health.

Viron Therapeutics Inc., a biotechnology company* which is developing immune-modulating protein therapeutics derived from pathogens, has recently reported encouraging results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus, in acute coronary syndrome (ACS) patients.